Pfizer offers the Pfizer Oncology Together™ program to patients prescribed a qualifying Pfizer product. At Pfizer Oncology Together, patient support is at the core of everything it does.
For more information, search the prescribed Pfizer product in this Guide, go online, or call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.
Oncology-related products: Aromasin® (exemestane) tablets, Besponsa® (inotuzumab ozogamicin) injection for IV infusion, Bosulif® (bosutinib) tablets, Braftovi® (encorafenib) capsules, Camptosar® (irinotecan hydrochloride) injection, Daurismo™ (glasdegib) tablets, Emcyt® (estramustine phosphate sodium) capsules, Ibrance® (palbociclib) capsules, Idamycin® (idarubicin hydrochloride) injection, Inlyta® (axitinib) tablets, Lorbrena® (lorlatinib) tablets, Mektovi® (binimetinib) tablets, Mylotarg™ (gemtuzumab ozogamicin) for injection, Nivestym® (filgrastim-aafi) injection, Nyvepria™ (pegfilgrastim-apgf) injection, Retacrit® (epoetin alfa-epbx) injection, Ruxience™ (rituximab-pvvr) injection, Sutent® (sunitinib malate) capsules, Talzenna® (talazoparib) capsules, Torisel® (temsirolimus) injection, Trazimera™ (trastuzumab-qyyp) injection, Vizimpro® (dacomitinib) tablets, Xalkori® (crizotinib) capsules, Zinecard® (dexrazoxane) for injection, Zirabev™ (bevacizumab-bvzr) injection
Patients who have been newly prescribed certain Pfizer Oncology medications may be able to start therapy with a free trial voucher. Patients who are new to their therapy with Bosulif, Ibrance, or Inlyta may be eligible for a free one-month free trial offer.
For more information, visit the prescribed medication website or call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.
If patients need access or reimbursement support for their prescribed Pfizer Oncology medications, Pfizer Oncology Together is here to help.
Benefits Verification
Pfizer Oncology Together can conduct a benefits verification to determine patients' health insurance coverage and out-of-pocket costs. After verifying coverage, the program will provide a summary of benefits for oral and injectable medications.
Prior Authorization Assistance
Pfizer Oncology Together will coordinate with a patient’s insurer to determine the prior authorization requirements, where and how to submit requests, and typical turnaround times. After the healthcare provider submits the request, the program will follow up with the insurer on behalf of the patient and track the progress and status, upon request.
Appeals Assistance
Pfizer Oncology Together can review the reasons for a denied claim and help with the appeals process by providing information on payer requirements.
Online Support
Log in to the provider portal for 24/7 access to helpful resources and information where registered users can complete and submit online enrollment forms, use secure messaging for inquires, and more.
For questions about a specific Pfizer Oncology product, a Pfizer Oncology account specialist can help provide detailed information—in your office or over the phone. Find your local representative online.
For more information and questions, call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.
Eligible, commercially insured patients may pay as little as $0 per month for their oral medication or per treatment for injectable medications. For oral products, patients may receive up to $25,000 per product in savings annually. For injectable products, the maximum annual patient savings range from $10,000 to $25,000.
Patients are not eligible for these programs if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TriCare, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. For oral products, the offer will be accepted only at participating pharmacies.
This offer is not health insurance. Pfizer reserves the right to rescind, revoke, or amend this offer without notice.
To enroll, go online or fax the completed enrollment form to 1.877.736.6506. For questions, call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.
Pfizer Oncology Together will assist patients with searching for financial support that may be available from independent charitable foundations. These foundations exist independently of Pfizer and have their own eligibility criteria and application processes. Availability of support from foundations is determined solely by the foundations.
The program will also check patient eligibility for Medicare Part D Low-Income Subsidy (Extra Help) for those patients on Medicare. If patients appear to be eligible based on income, the program can help patients understand how to apply.
For questions, call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.
Eligible patients may receive up to a 90-day supply of Pfizer medication for free, while applying for Medicaid. If patients do not qualify for Medicaid, they may be able to receive their medication for free for up to one year through the Pfizer Patient Assistance Program. Patients must meet eligibility requirements and reapply as needed.
If support from independent charitable foundations or Medicare Extra Help is not available, they may be eligible to enroll in the Pfizer Patient Assistance Program.
To be evaluated for assistance through the Pfizer Patient Assistance Program, healthcare professionals and their patients must submit a completed enrollment form. Patients must also provide proof of income, such as the prior year’s tax return, a W2 form, or a paycheck stub. They also must:
If a patient is accepted into the Pfizer Patient Assistance Program, the program will inform the healthcare professional by fax and phone and the patient by phone and letter. Uninsured patients may receive free medication for up to one calendar year, while underinsured patients are enrolled through the end of the calendar year.
To enroll patients, go online or fax the completed enrollment form to 1.877.736.6506. For questions, call 1.877.744.5675, Monday through Friday, 8:00 AM to 8:00 PM EST.